STOCK TITAN

Alkermes plc (NASDAQ: ALKS) insider files to sell 5,000 shares of stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Alkermes plc insider Craig Hopkinson has filed a Form 144 notice to sell ordinary shares. The filing covers 5,000 ordinary shares to be sold through Merrill Lynch on or about 01/08/2026 on NASDAQ, with an aggregate market value of $150,004.95. The filing notes 165,117,509 ordinary shares outstanding.

The 5,000 shares were acquired on 01/08/2025 through the exercise of employee stock options in a broker-assisted cashless exercise. The notice also lists prior sales over the past three months, including 9,000 ordinary shares sold on 10/15/2025 for gross proceeds of $283,776.70 and 9,000 shares sold on 11/03/2025 for $273,441.50, along with additional smaller transactions in December 2025 and early January 2026.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Alkermes (ALKS) Form 144 filing disclose?

The Form 144 filing discloses that Craig Hopkinson, an insider of Alkermes plc, plans to sell 5,000 ordinary shares on NASDAQ through Merrill Lynch, with an aggregate market value of $150,004.95, subject to Rule 144 conditions.

How many Alkermes (ALKS) shares is the insider planning to sell under this Form 144?

The notice covers the planned sale of 5,000 ordinary shares of Alkermes plc, with an indicated aggregate market value of $150,004.95 at the time of the filing.

When were the Alkermes (ALKS) shares to be sold under Form 144 acquired and how?

The 5,000 ordinary shares to be sold were acquired on 01/08/2025 through the exercise of employee stock options in a broker-assisted cashless exercise from Alkermes plc.

On which exchange and through which broker will the Alkermes (ALKS) shares be sold?

The filing states that the 5,000 ordinary shares are expected to be sold on the NASDAQ exchange through Merrill Lynch, located at 225 Liberty St, Floor 37, New York, NY 10281.

How many Alkermes (ALKS) shares are outstanding according to the Form 144?

The Form 144 indicates that there are 165,117,509 ordinary shares of Alkermes plc outstanding at the time referenced in the notice.

What other recent sales by the Alkermes (ALKS) insider are reported in the past 3 months?

The filing lists several prior sales by Craig Hopkinson in the past three months, including 9,000 ordinary shares sold on 10/15/2025 for $283,776.70, 9,000 shares on 11/03/2025 for $273,441.50, and additional sales in December 2025 and 01/02/2026.

Alkermes Plc

NASDAQ:ALKS

ALKS Rankings

ALKS Latest News

ALKS Latest SEC Filings

ALKS Stock Data

5.24B
161.98M
1.49%
104.97%
8.06%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Ireland
DUBLIN 4